CDER Director Dr. Pazdur to Retire, Dr. Høeg Named as Replacement and Other CDER Leadership Changes, the U.S. House of Representatives Passes Rare Pediatric Disease Voucher Bill, and FDA’s Draft Guidance on Reducing Testing on Non-Human Primates for Monoclonal Antibodies

December 10, 2025

Through our Venable FDA Pulse series, we provide insight into key developments within the Food and Drug Administration (FDA or the Agency), emerging trends, enforcement activity, and other topics impacting stakeholders….
By: Venable LLP

CDER Director Dr. Pazdur to Retire, Dr. Høeg Named as Replacement and Other CDER Leadership Changes, the U.S. House of Representatives Passes Rare Pediatric Disease Voucher Bill, and FDA’s Draft Guidance on Reducing Testing on Non-Human Primates for Monoclonal Antibodies

FTC’s Illuminate Education Order Serves as a Data Deletion Reminder

AI May Be Rewriting Law Firm Sales. Managing Partners Should Pay Attention